DescriptionTheratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 2.61 +0.77% increase |
| 3.16 -16.77% decrease |
| -0.30 (-10.24%) decrease |
|3-Month|| 2.61 +0.77% increase |
| 3.99 -34.09% decrease |
| -0.72 (-21.49%) decrease |
|52-Week|| 1.93 +36.27% increase |
| 5.40 -51.30% decrease |
| -2.57 (-49.42%) decrease |